BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12356421)

  • 21. Enhancement of sodium taurocholate to the absorption of cefquinome.
    Yu Q; Cao Y; Liu LF; Jiang SX; Yang Q
    Pak J Pharm Sci; 2016 Jan; 29(1):139-43. PubMed ID: 26826827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
    Liu DZ; LeCluyse EL; Thakker DR
    J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SEDDS for intestinal absorption of insulin: Application of Caco-2 and Caco-2/HT29 co-culture monolayers and intra-jejunal instillation in rats.
    Liu J; Werner U; Funke M; Besenius M; Saaby L; Fanø M; Mu H; Müllertz A
    Int J Pharm; 2019 Apr; 560():377-384. PubMed ID: 30790612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers.
    Ingels F; Beck B; Oth M; Augustijns P
    Int J Pharm; 2004 Apr; 274(1-2):221-32. PubMed ID: 15072798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transport evaluation of alendronate across Caco-2 cell monolayers.
    Karamustafa F; Celebi N; Değim Z; Unal N
    Pharmazie; 2009 Feb; 64(2):98-103. PubMed ID: 19320282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.
    Muendoerfer M; Schaefer UF; Koenig P; Walk JS; Loos P; Balbach S; Eichinger T; Lehr CM
    Int J Pharm; 2010 Jun; 392(1-2):134-40. PubMed ID: 20347022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticle and liposome formulations of doxycycline: transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion.
    Yücel C; Değim Z; Yilmaz S
    Biomed Pharmacother; 2013 Jul; 67(6):459-67. PubMed ID: 23583191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A physicochemical basis for the effect of food on the absolute oral bioavailability of halofantrine.
    Humberstone AJ; Porter CJ; Charman WN
    J Pharm Sci; 1996 May; 85(5):525-9. PubMed ID: 8742945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing the Biopharmacological Characteristics of Asperosaponin VI: Unveiling Dynamic Self-Assembly Phase Transitions in the Gastrointestinal Environment.
    Mo Y; Yang Y; Zeng J; Ma W; Guan Y; Guo J; Wu X; Liu D; Feng L; Jia X; Yang B
    Int J Nanomedicine; 2023; 18():7335-7358. PubMed ID: 38084126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers.
    Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M
    J Pharm Pharmacol; 1999 Jan; 51(1):27-33. PubMed ID: 10197414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Permeation of insulin, calcitonin and exenatide across Caco-2 monolayers: measurement using a rapid, 3-day system.
    Gupta V; Doshi N; Mitragotri S
    PLoS One; 2013; 8(2):e57136. PubMed ID: 23483881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
    Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
    J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical and biological characterization of monoketocholic acid, a novel permeability enhancer.
    Yang L; Zhang H; Mikov M; Tucker IG
    Mol Pharm; 2009; 6(2):448-56. PubMed ID: 19718798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
    Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
    Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development, validation, and application of a novel 7-day Caco-2 cell culture system.
    Cai Y; Xu C; Chen P; Hu J; Hu R; Huang M; Bi H
    J Pharmacol Toxicol Methods; 2014; 70(2):175-81. PubMed ID: 25034865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of capsaicin on cellular damage and monolayer permeability in human intestinal Caco-2 cells.
    Tsukura Y; Mori M; Hirotani Y; Ikeda K; Amano F; Kato R; Ijiri Y; Tanaka K
    Biol Pharm Bull; 2007 Oct; 30(10):1982-6. PubMed ID: 17917278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial transport of drugs in cell culture. VIII: Effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cells.
    Anderberg EK; Artursson P
    J Pharm Sci; 1993 Apr; 82(4):392-8. PubMed ID: 8468683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of the tight junctions of the Caco-2 cell monolayers by H2-antagonists.
    Gan LS; Yanni S; Thakker DR
    Pharm Res; 1998 Jan; 15(1):53-7. PubMed ID: 9487546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers.
    El-Sayed M; Ginski M; Rhodes C; Ghandehari H
    J Control Release; 2002 Jun; 81(3):355-65. PubMed ID: 12044574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.